BenevolentAI
ben phase progressing phase double blind placebo controlled in patient two part clinical study day day day day active recruiting sites in the in a further sites under approval recruitment completion anticipated our intention is to to partner this asset with a pharmaceutical company that has a focus in dermatology for continued clinical development and if approved our intention is to out development and of ben following completion of this trial with key big and dermatology specialists as potential part | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
40 of 46
Similar slides by BenevolentAI
See diffirences between slides (animation)
Investor Day
September 2022
ben phase progressing phase double blind placebo controlled in patient two part clinical study day day day day active recruiting sites in the in a further sites under approval recruitment completion anticipated our intention is to to partner this asset with a pharmaceutical company that has a focus in dermatology for continued clinical development and if approved our intention is to out development and of ben following completion of this trial with key big and dermatology specialists as potential part | BenevolentAI
Related slides by other companies
Alkermes
Investor Presentation
March 2023
clinical development plan designed to rapidly advance program in | Alkermes
NeuroSense Therapeutics
Investor Presentation
January 2024
strong clinical and commercial potential | NeuroSense Therapeutics
Equillium
Investor Presentation
February 2024
milestones | Equillium
Equillium
Investor Presentation
December 2023
milestones | Equillium
Other recent decks by BenevolentAI
See all presentations (10 decks)
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io